Royalty Pharma (RPRX) Short Interest Ratio & Short Volume → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free RPRX Stock Alerts $27.05 +0.66 (+2.50%) (As of 12:21 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Royalty Pharma Short Interest DataCurrent Short Interest13,280,000 sharesPrevious Short Interest13,750,000 sharesChange Vs. Previous Month-3.42%Dollar Volume Sold Short$374.63 millionShort Interest Ratio5.1 Days to CoverLast Record DateMay 15, 2024Outstanding Shares597,440,000 sharesFloat Size382,930,000 sharesShort Percent of Float3.47%Today's Trading Volume1,054,187 sharesAverage Trading Volume2,695,125 sharesToday's Volume Vs. Average39% Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartRPRX Short Interest Over TimeRPRX Days to Cover Over TimeRPRX Percentage of Float Shorted Over Time Ad Porter & CompanyKiss of death from Joe BidenIn this new documentary, you’ll discover the truth about Trump’s criminal conviction, who’s really pulling the puppet strings, and why this is just phase one in their dark plan to reshape America. It’s not just about blocking Trump’s re-election… To get all the details, go here now. Royalty Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/202413,280,000 shares $374.63 million -3.4%3.5%5.1 $28.21 4/30/202413,750,000 shares $380.88 million -2.8%3.6%4.8 $27.70 4/15/202414,150,000 shares $399.74 million +14.2%3.7%5.2 $28.25 3/31/202412,390,000 shares $376.28 million -2.1%3.3%4.7 $30.37 3/15/202412,650,000 shares $380.64 million -3.7%3.3%4.9 $30.09 2/29/202413,130,000 shares $398.36 million +14.2%3.5%4.8 $30.34Elon Musk’s Final Masterpiece: “X-9840” (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. 2/15/202411,500,000 shares $345.35 million +11.9%3.0%4.1 $30.03 1/31/202410,280,000 shares $291.85 million +0.9%2.7%4.1 $28.39 1/15/202410,190,000 shares $289.19 million -9.1%2.7%4.3 $28.38 12/31/202311,210,000 shares $314.89 million -9.2%2.9%4.8 $28.09 12/15/202312,340,000 shares $337.75 million +23.3%3.2%5.3 $27.37 11/30/202310,010,000 shares $270.97 million +1.8%2.6%4.3 $27.07 11/15/20239,830,000 shares $265.61 million -10.4%2.6%4.5 $27.02 10/31/202310,970,000 shares $294.76 million -2.8%2.9%5 $26.87 10/15/202311,290,000 shares $314.31 million +8.0%3.0%5.2 $27.84 9/30/202310,450,000 shares $283.61 million +11.7%2.8%4.8 $27.14 9/15/20239,360,000 shares $263.30 million +9.5%2.5%4.3 $28.13 8/31/20238,550,000 shares $254.96 million -8.7%2.3%3.7 $29.82 8/15/20239,360,000 shares $278.93 million +0.2%2.5%3.9 $29.80 7/31/20239,340,000 shares $293.09 million -14.2%2.5%3.9 $31.38 7/15/202310,890,000 shares $334.65 million +23.2%2.9%4.6 $30.73 6/30/20238,840,000 shares $271.74 million +1.1%2.4%3.9 $30.74 6/15/20238,740,000 shares $281.43 million +15.3%2.3%4 $32.20 5/31/20237,580,000 shares $248.17 million +5.6%2.0%3.7 $32.74 5/15/20237,180,000 shares $246.49 million -7.4%1.9%3.7 $34.33 4/30/20237,750,000 shares $272.41 million +1.7%2.1%4.1 $35.15 4/15/20237,620,000 shares $276.30 million +0.9%2.1%4.1 $36.26 3/31/20237,550,000 shares $272.03 million -1.2%2.0%4 $36.03 3/15/20237,640,000 shares $263.58 million +3.7%2.1%4.2 $34.50 2/28/20237,370,000 shares $264.21 million +7.1%2.0%4.5 $35.85 2/15/20236,880,000 shares $259.31 million +8.2%1.9%4.4 $37.69 1/31/20236,360,000 shares $249.25 million -10.4%1.7%4.2 $39.19 1/15/20237,100,000 shares $279.53 million -9.0%1.9%4.8 $39.37 12/30/20227,800,000 shares $308.26 million +4.4%2.1%5.3 $39.52 12/15/20227,470,000 shares $304.70 million -2.9%2.0%4.9 $40.79 11/30/20227,690,000 shares $338.13 million +35.6%2.1%4.7 $43.97 11/15/20225,670,000 shares $238.59 million -14.7%1.6%3.4 $42.08 10/31/20226,650,000 shares $281.43 million -22.1%1.8%4.1 $42.32 10/15/20228,540,000 shares $353.64 million -0.5%2.4%5 $41.41 9/30/20228,580,000 shares $344.74 million -5.3%2.4%4.6 $40.18Elon Musk’s Final Masterpiece: “X-9840” (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. 9/15/20229,060,000 shares $382.06 million -9.9%2.5%4.6 $42.17 8/31/202210,050,000 shares $420.19 million -17.3%2.8%5.2 $41.81 8/15/202212,150,000 shares $533.75 million -10.0%3.3%6.2 $43.93 7/31/202213,500,000 shares $587.12 million +0.5%3.7%6.4 $43.49 7/15/202213,430,000 shares $589.98 million +0.8%3.7%6.2 $43.93 6/30/202213,330,000 shares $560.39 million -2.9%3.7%5.7 $42.04 6/15/202213,730,000 shares $529.02 million +35.9%3.8%5.7 $38.53 5/31/202210,100,000 shares $415.51 million +21.0%2.8%4.7 $41.14 5/15/20228,350,000 shares $333.50 million +13.5%2.3%4 $39.94 4/30/20227,360,000 shares $313.39 million -10.1%2.0%3.8 $42.58 4/15/20228,190,000 shares $361.18 million +17.5%2.3%4.4 $44.10 3/31/20226,970,000 shares $271.55 million +11.3%1.9%4.1 $38.96 3/15/20226,260,000 shares $239.57 million +4.5%1.7%4.1 $38.27 2/28/20225,990,000 shares $235.17 million +7.2%1.7%3.7 $39.26 2/15/20225,590,000 shares $225.50 million -7.3%1.6%3 $40.34 1/31/20226,030,000 shares $241.26 million -4.3%1.7%2.9 $40.01 1/15/20226,300,000 shares $249.86 million +7.7%1.8%2.9 $39.66 12/31/20215,850,000 shares $233.12 million -17.7%1.6%2.8 $39.85 12/15/20217,110,000 shares $266.77 million +20.3%2.0%3.5 $37.52 11/30/20215,910,000 shares $235.04 million -10.1%1.7%2.4 $39.77 11/15/20216,570,000 shares $273.97 million -17.6%1.9%2.8 $41.70 10/29/20217,970,000 shares $315.05 million +2.1%2.4%3.7 $39.53 10/15/20217,810,000 shares $299.83 million -7.4%2.3%3.3 $38.39 9/30/20218,430,000 shares $304.66 million +40.3%2.5%3.5 $36.14 9/15/20216,010,000 shares $228.20 million +2.2%1.8%2.4 $37.97 8/31/20215,880,000 shares $227.26 million -22.5%1.8%2.7 $38.65 8/13/20217,590,000 shares $293.96 million -15.6%2.3%3.3 $38.73 7/30/20218,990,000 shares $343.42 million -11.5%3.0%4 $38.20 7/15/202110,160,000 shares $407.21 million +8.6%3.4%5.3 $40.08 6/30/20219,360,000 shares $383.67 million -30.3%3.1%4.9 $40.99 6/15/202113,420,000 shares $590.75 million -15.7%4.5%7.6 $44.02 5/28/202115,910,000 shares $638.31 million -12.4%5.3%6.5 $40.12 5/14/202118,170,000 shares $730.07 million +10.6%6.1%7.2 $40.18 4/30/202116,430,000 shares $727.85 million -8.1%5.4%6.3 $44.30 4/15/202117,880,000 shares $753.11 million -1.4%5.9%6.7 $42.12 3/31/202118,140,000 shares $791.45 million +30.1%6.0%6 $43.63 3/15/202113,940,000 shares $654.06 million +31.0%4.6%3.9 $46.92 2/26/202110,640,000 shares $500.29 million +31.5%3.5%3.7 $47.02 2/12/20218,090,000 shares $382.74 million -7.1%2.6%3 $47.31 1/29/20218,710,000 shares $423.83 million -3.3%2.8%3.3 $48.66 1/15/20219,010,000 shares $461.76 million No Change2.9%3.4 $51.25 RPRX Short Interest - Frequently Asked Questions What is Royalty Pharma's current short interest? Short interest is the volume of Royalty Pharma shares that have been sold short but have not yet been covered or closed out. As of May 15th, traders have sold 13,280,000 shares of RPRX short. 3.47% of Royalty Pharma's shares are currently sold short. Learn More on Royalty Pharma's current short interest. What is a good short interest ratio for Royalty Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RPRX shares currently have a short interest ratio of 5.0. Learn More on Royalty Pharma's short interest ratio. Which institutional investors are shorting Royalty Pharma? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Royalty Pharma: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Royalty Pharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 3.47% of Royalty Pharma's floating shares are currently sold short. Is Royalty Pharma's short interest increasing or decreasing? Royalty Pharma saw a decrease in short interest in the month of May. As of May 15th, there was short interest totaling 13,280,000 shares, a decrease of 3.4% from the previous total of 13,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Royalty Pharma's float size? Royalty Pharma currently has issued a total of 597,440,000 shares. Some of Royalty Pharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Royalty Pharma currently has a public float of 382,930,000 shares. How does Royalty Pharma's short interest compare to its competitors? 3.47% of Royalty Pharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Royalty Pharma: Jazz Pharmaceuticals plc (5.20%), Perrigo Company plc (3.08%), Corcept Therapeutics Incorporated (22.07%), Supernus Pharmaceuticals, Inc. (9.33%), Pacira BioSciences, Inc. (12.98%), Nektar Therapeutics (1.49%), Omeros Co. (24.44%), Assembly Biosciences, Inc. (0.58%), Cumberland Pharmaceuticals Inc. (0.37%), Regeneron Pharmaceuticals, Inc. (1.48%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short Royalty Pharma stock? Short selling RPRX is an investing strategy that aims to generate trading profit from Royalty Pharma as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Royalty Pharma? A short squeeze for Royalty Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RPRX, which in turn drives the price of the stock up even further. How often is Royalty Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RPRX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: JAZZ Short Interest PRGO Short Interest CORT Short Interest SUPN Short Interest PCRX Short Interest NKTR Short Interest OMER Short Interest ASMB Short Interest CPIX Short Interest REGN Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RPRX) was last updated on 5/31/2024 by MarketBeat.com Staff From Our Partners[Urgent!] Generational Wealth GameplanCrypto 101 MediaThis unknown company solves the biggest issue with AIManward PressWho are Nvidia’s New Silent Partners?Weiss RatingsThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarBill Gates is all about this tiny $2 stockTimothy SykesHow Biden has already won 2024Porter & CompanyDems have chosen Biden replacement?Paradigm PressGold Set to EXPLODE!Gold Safe Exchange Adding Choose a watchlist: Watchlist My Default Watchlist Adding Royalty Pharma plc You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.